Lee Su | Targeted Medicine Research Center, Korea Research Institute of Bioscience and Biotechnology
スポンサーリンク
概要
- Lee Su Uiの詳細を見る
- 同名の論文著者
- Targeted Medicine Research Center, Korea Research Institute of Bioscience and Biotechnologyの論文著者
関連著者
-
Lee Su
Targeted Medicine Research Center, Korea Research Institute of Bioscience and Biotechnology
-
Cho Sungchan
Targeted Medicine Research Center, Korea Research Institute of Bioscience and Biotechnology
-
Lee Sangku
Targeted Medicine Research Center, Korea Research Institute of Bioscience and Biotechnology
-
Lee Hyun-Jun
Targeted Medicine Research Center, Korea Research Institute of Bioscience and Biotechnology
-
Kim Sunhong
Targeted Medicine Research Center, Korea Research Institute of Bioscience and Biotechnology
-
Park Bi-oh
Targeted Medicine Research Center, Korea Research Institute of Bioscience and Biotechnology
-
Oh Soo
Bio-Evaluation Center, Korea Research Institute of Bioscience and Biotechnology
-
In Hyun
Targeted Medicine Research Center, Korea Research Institute of Bioscience and Biotechnology
-
Kwon Mi
Targeted Medicine Research Center, Korea Research Institute of Bioscience and Biotechnology
-
Jo Minmi
College of Pharmacy, Korea University
-
Kim Mun-Ock
Targeted Medicine Research Center, Korea Research Institute of Bioscience and Biotechnology
-
Kwak Young
College of Pharmacy, Korea University
-
Kim Mun
Targeted Medicine Research Center, Korea Research Institute of Bioscience and Biotechnology
-
Choi Kwangman
Targeted Medicine Research Center, Korea Research Institute of Bioscience and Biotechnology
-
Kim Hyeongki
Targeted Medicine Research Center, Korea Research Institute of Bioscience and Biotechnology
-
Kang Jong
Bio-Evaluation Center, Korea Research Institute of Bioscience and Biotechnology
-
Lee Hyun
Targeted Medicine Research Center, Korea Research Institute of Bioscience and Biotechnology
-
Kwak Young-Shin
College of Pharmacy, Korea University
著作論文
- β-Arrestin 2 mediates G protein-coupled receptor 43 signals to Nuclear Factor-κB
- Identification and validation of a selective small molecule inhibitor targeting the diacylglycerol acyltransferase 2 activity